Microcirculatory dysfunction in acute pancreatitis: A new concept of pathogenesis involving vasomotion-associated arteriolar constriction and dilation

Pancreatology

Volumn 3, Issue 3, 2003, Pages 181-190

  Vollmar, Brigitte ^a   Menger, Michael D ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Endothelin; Hypovolemic shock; Inflammation; Ischemia reperfusion; Nitric oxide; Nitric oxide synthase; No reflow; Reflow paradox; Resuscitation; Vasomotor dysfunction

Indexed keywords

BRADYKININ ANTAGONIST; ENDOTHELIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; N(G) METHYLARGININE; NITRIC OXIDE; PHOSPHOLIPASE A2 INHIBITOR; RECEPTOR BLOCKING AGENT; SUPEROXIDE DISMUTASE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; CAUSE OF DEATH; CELL ACTIVITY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; HYPOVOLEMIC SHOCK; INFLAMMATORY CELL; ISCHEMIA; LEUKOCYTE; MICROANGIOPATHY; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS INJURY; PANCREAS PERFUSION; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASOMOTOR DISORDER;

EID: 0038653438     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000070727     Document Type: Review

References (159)

1. Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
2. Banerjee AK, Steele RJC: Current views on the pathophysiology of acute biliary pancreatitis. Gut 1995;36:803-805.
3. Singh M, Simsek H: Ethanol and the pancreas. Current status. Gastroenterology 1990;98:1051-1062.
4. Slater DN, Bardsley D, Magnall Y, Smythe A, Fox M: Pancreatic ischaemia: Sensitivity and reversibility of the changes. Br J Exp Pathol 1975;56:530-536.
5. Popper HB, Necheles H, Russell KC: Transition of pancreatic edema into pancreatic necrosis. Surg Gynecol Obstet 1948;87:79-82.
6. Pfeffer RB, Lazzarini-Robertson A Jr, Safadi D, Mixter G, Secoy CF, Hinton JW: Gradation of pancreatitis, edematous, through hemorrhagic, experimentally produced by controlled injection of microspheres into blood vessels in dogs. Surgery 1962;51:764-769.
7. Broe PJ, Zuidema GD, Cameron JL: The role of ischemia in acute pancreatitis: Studies with an isolated perfused canine pancreas. Surgery 1982;91:377-382.
8. Haas GS, Warshaw AL, Daggett WM, Aretz HT: Acute pancreatitis after cardiopulmonary bypass. Am J Surg 1985;149:508-515.
9. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL: Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 1989;209:279-283.
10. Warshaw AL, O'Hara PJ: Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1976;188:197-201.
11. Mithöfer K, Fernández-del-Castillo C, Frick TW, Foitzik T, Bassi DG, Lewandrowski KB, Rattner DW, Warshaw AL: Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis. Ann Surg 1995;221:364-371.
12. Klar E, Messmer K, Warshaw AL, Herfarth C: Pancreatic ischaemia in experimental acute pancreatitis: Mechanism, significance and therapy. Br J Surg 1990;77:1205-1210.
13. Menger MD, Plusczyk T, Vollmar B: Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001;8:187-194.
14. Menger MD, Vollmar B: Microcirculation: Initiating or aggravating factor; in Büchler MW, Uhl W, Friess H, Malfertheiner P (eds): Acute Pancreatitis: Novel Concepts in Biology and Therapy. Berlin, Blackwell Sciences, 1999, pp 63-70.
15. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N: Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: Evidence of a role for superoxide anion. Hepatology 1992;15:507-514.
16. Crissinger KD, Granger DN: Mucosal injury induced by ischemia and reperfusion in the piglet intestine: influences of age and feeding. Gastroenterology 1989;97:920-926.
17. Parks DA, Granger DN: Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986;548:87-99.
18. Korthuis RJ, Smith JK, Carden DL: Hypoxic reperfusion attenuates postischemic microvascular injury. Am J Physiol 1989;256:H315-H319.
19. Sexton WL, Korthuis RJ, Laughlin MH: Ischemia-reperfusion injury in isolated rat hindquarters. J Appl Physiol 1990;68:387-392.
20. Walker PMV, Lindsay TF, Labbe R, Mickle DA, Romaschin AD: Salvage of skeletal muscle with free radical scavengers. J Vasc Surg 1987;5:68-75.
21. Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia-reperfusion injury via ICAM-1 mediated microvascular adherence. Surgery 1995;117:195-200.
22. Menger, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of 'no reflow'. Am J Physiol 1992;263:H1892-H1900.
23. Menger MD, Pelikan S, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of 'reflow paradox'. Am J Physiol 1992;263:H1901-H1906.
24. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K: Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991;87:2036-2042.
25. Nordback IH, Clemens JA, Chacko VP, Olson JL, Cameron JL: Changes in high-energy phosphate metabolism and cell morphology in four models of acute experimental pancreatitis. Ann Surg 1991;213:341-349.
26. Spormann H, Sokolowski A, Letko G: Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Pathol Res Pract 1989;184:507-513.
27. Menger MD, Bonkhoff H, Vollmar B: Ischemia/reperfusion-induced pancreatic microvascular injury: An intravital fluorescence microscopic study in rats. Dig Dis Sci 1996;41:823-830.
28. Vollmar B, Hoffmann T, Menger MD, Messmer K: Microvascular ischemia/reperfusion injury in the pancreas of rats. Digestion 1992;52:S130.
29. Hoffmann TF, Leiderer R, Waldner H, Arbogast S, Messmer K: Ischemia reperfusion of the pancreas: A new in vivo model for acute pancreatitis in rats. Res Exp Med 1995;195:125-144.
30. Von Dobschuetz E, Hoffmann T, Engelschalk C, Messmer K: Effect of diaspirin cross-linked hemoglobin on normal and postischemic microcirculation of the rat pancreas. Am J Physiol 1999a;276:G1507-G1514.
31. Von Dobschuetz E, Hoffmann T, Messmer K: Inhibition of neutrophil proteinases by recombinant serpin Lex032 reduces capillary no-reflow in ischemia/reperfusion-induced acute pancreatitis. J Pharmacol Exp Ther 1999;290:782-788.
32. Obermaier R, Benz S, von Dobschuetz E, Drognitz O, Schareck W, Jonas L, Messmer K, Hopt UT: Characterization of microcirculatory disturbance in a novel model of pancreatic ischemia-reperfusion using intravital fluorescence-microscopy. Pancreas 2002;25:142-148.
33. Vollmar B, Janata J, Yamauchi J, Wolf B, Heuser M, Menger MD: Exocrine, but not endocrine, tissue is susceptible to microvascular ischemia/reperfusion injury following pancreas transplantation in the rat. Transpl Int 1999;12:50-55.
34. Vollmar B, Janata J, Yamauchi JI, Menger MD: Attenuation of microvascular reperfusion injury in rat pancreas transplantation by L-arginine. Transplantation 1999;67:950-955.
35. Vollmar B, Glasz J, Post S, Leiderer R, Menger MD: Hepatic microcirculatory perfusion failure is a determinant for liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994;145:1421-1431.
36. Vollmar B, Menger MD, Glasz J, Messmer K: Impact of leukocyte-endothelial cell interaction in hepatic ischemia/reperfusion injury. Am J Physiol 1994;267:G786-G793.
37. Kuhnle GE, Reichenspurner H, Lange T, Wagner F, Groh J, Messmer K, Goetz AE: Microhemodynamics and leukocyte sequestration after pulmonary ischemia and reperfusion in rabbits. J Thorac Cardiovasc Surg 1998;115:937-944.
38. Gonzalez AP, Sepulveda S, Massberg S, Baumeister R, Menger MD: In vivo fluorescence microscopy for the assessment of microvascular reperfusion injury in small bowel transplants in rats. Transplantation 1994;58:403-408.
39. Massberg S, Gonzalez AP, Leiderer R, Menger MD, Messmer K: In vivo assessment of the influence of cold preservation time on microvascular reperfusion injury after experimental small bowel transplantation. Br J Surg 1998;85:127-133.
40. Massberg S, Leiderer R, Gonzalez AP, Menger MD, Messmer K: Carolina rinse attenuates postischemic microvascular injury in rat small bowel isografts. Surgery 1998;123:181-190.
41. Bartlett R, Funk W, Hammersen F, Arfors KE, Messmer K, Nemir P: Effect of superoxide dismutase on skin microcirculation after ischemia and reperfusion. Surg Forum 1986;37:599-601.
42. Klar E, Endrich B, Messmer K: Microcirculation of the pancreas. A quantitative study of physiology and changes in pancreatitis. Int J Microcirc Clin Exp 1990;9:85-101.
43. Kusterer K, Poschmann T, Friedmann A, Enghofer M, Zendler S, Usadel KH: Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993;265:G165-G171.
44. Plusczyk T, Rathgeb D, Westermann S, Feifel G: Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis. Dig Dis Sci 1998;43:575-585.
45. Büsing M, Hopt UT, Quacken M, Becker HD, Morgenroth K: Morphological studies of graft pancreatitis following pancreas transplantation. Br J Surg 1993;80:1170-1173.
46. Benz S, Bergt S, Obermaier R, Wiessner R, Pfeffer F, Schareck W, Hopt UT: Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation 2001;27:759-763.
47. Fernández-Cruz L, Sabater L, Gilabert R, Ricart MJ, Saenz A, Astudillo E: Native and graft pancreatitis following combined pancreas-renal transplantation. Br J Surg 1993;80:1429-1432.
48. Douzdjian V, Abecassis MM, Cooper JL, Smith JL, Corry RJ: Incidence, management and significance of surgical complications after pancreatic transplantation. Surg Gynecol Obstet 1993;177:451-456.
49. Grewal HP, Garland L, Novak K, Gaber L, Tolley EA, Gaber AO: Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation 1993;56:609-612.
50. Stratta RJ, Taylor RJ, Lowell JA, Byon JS, Cattral M, Langnas AN, Shaw BW: Selective use of sandostatin in vascularized pancreas transplantation. Am J Surg 1993;166:598-604.
51. Knoefel WT, Kollias N, Warshaw AL, Waldner H, Nishioka N, Rattner DW: Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 1994;116:904-913.
52. Kerner T, Vollmar B, Menger MD, Waldner H, Messmer K: Determinants of pancreatic microcirculation in acute pancreatitis in rats. J Surg Res 1996;62:165-171.
53. Sanfey H, Broe PJ, Cameron JL: Experimental ischemic pancreatitis: Treatment with albumin. Am J Surg 1985;150:297-300.
54. Hirano T, Hirano K: Thromboxane A2 receptor antagonist prevents pancreatic microvascular leakage in rats with caerulein-induced acute pancreatitis. Int J Surg Invest 1999;1:203-210.
55. Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T: Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut 2000;46:390-394.
56. Gross V, Schölmerich J, Leser H-G, Salm R, Lausen M, Rückauer K, Schöffel U, Lay L, Heinisch A, Farthmann EH, Gerok W: Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha-2-macroglobulin. Dig Dis Sci 1990;35:97-105.
57. Dominguez-Muñoz JE, Carballo F, Garcia MJ, de Diego JM, Simón MA, de la Morena J: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicenter study. Br J Surg 1991;78:1230-1234.
58. Balthazar EJ: CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am 1989;27:19-37.
59. Larvin M, Chalmers AG, McMahon MJ: Dynamic contrast enhanced computed tomography: A precise technique for identifying and localising pancreatic necrosis. BMJ 1990;300:1425-1428.
60. Formela LJ, Galloway SW, Kingsnorth AN: Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
61. Toyama MT, Lewis MP, Kusske AM, Reber PU, Ashley SW, Reber HA: Ischemia-reperfusion mechanisms in acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:20-23.
62. Lewis MPN, REber HA, Ashley SW: Pancreatic blood flow and its role in the pathophysiology of pancreatitis. J Surg Res 1998;75:81-89.
63. Klar E, Werner J: New pathophysiologic knowledge about acute pancreatitis. Chirurg 2000;71:253-264.
64. Kyogoku T, Manabe T, Tobe T: Role of ischemia in acute pancreatitis. Hemorrhagic shock converts edematous pancreatitis to hemorrhagic pancreatitis in rats. Dig Dis Sci 1992;37:1409-1417.
65. Feiner H: Pancreatitis after cardiac surgery: A morphologic study. Am J Surg 1976;149:508-514.
66. Fernandez-del-Castillo C, Harringer W, Warshaw AL, Vlahakes GJ, Koski G, Zaslavsky AM, Rattner DW: Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991;325:382-387.
67. Rose DM, Ranson JHC, Cunningham JN Jr, Spencer FC: Patterns of severe pancreatic injury following cardiopulmonary bypass. Ann Surg 1984;199:168-172.
68. Svensson LG, Decker G, Kinsley RB: A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass. Ann Thorac Surg 1985;39:409-411.
69. Vollmar B, Preissler G, Menger MD: Hemorrhage induce arteriolar vasomotion and intermittent capillary perfusion in rat pancreas. Am J Physiol 1994;267:H1936-H1940.
70. Yamaguchi H, Kimura T, Nawata H: Does stress play a role in the development of severe pancreatitis in rats? Gastroenterology 1990;98:1682-1688.
71. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
72. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269-H1275.
73. Welbourn CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischemia reperfusion injury: Central role of the neutrophil. Br J Surg 1991;78:651-655.
74. Menger MD, Vollmar B, Glasz J, Post S, Messmer K: Microcirculatory manifestations of hepatic ischemia/reperfusion injury. Prog Appl Microcirc 1993;19:106-124.
75. Rinderknecht H: Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-112.
76. Vollmar B, Waldner H, Schmand J, Conzen PF, Goetz AE, Habazettl H, Schweiberer L, Brendel W: Release of arachidonic acid metabolites during acute pancreatitis in pigs. Scand J Gastroenterol 1989;24:1253-1264.
77. Vollmar B, Waldner H, Schmand J, Conzen PF, Goetz AE, Habazettl H, Schweiberer L, Brendel W: Oleic acid induced pancreatitis in pigs. J Surg Res 1991;50:196-204.
78. Gough DB, Boyle B, Joyce WP, Delaney CP, McGeeney KF, Gorey TF, Fitzpatrick JM: Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis. Br J Surg 1990;77:1256-1259.
79. Hirano T, Manabe T, Steer M, Printz H, Calne R, Tobe T: Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Surg Gynecol Obstet 1993;176:371-381.
80. Schoenberg MH, Büchler M, Beger HG: The role of oxygen radicals in experimental acute pancreatitis. Free Rad Biol Med 1992;12:515-522.
81. Schoenberg MH, Büchler M, Younes M, Kirchmayr R, Brückner UB, Beger HG: Effect of antioxidant treatment in rats with acute hemorrhagic pancreatitis. Dig Dis Sci 1994;39:1034-1040.
82. Wang XD, Deng XM, Haraldsen P, Andersson R, Ihse I: Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. Scand J Gastroenterol 1995;30:1129-1136.
83. Kuroda T, Shiohara E, Homma T, Furukawa Y, Chiba S: Effects of leukocyte and platelet depletion on ischemia-reperfusion injury to dog pancreas. Gastroenterology 1994;107:1125-1134.
84. Odeh M: The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 1991;324:1417-1422.
85. Ward JB, Petersen OH, Jenkins SA, Sutton R: Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis? Lancet 1995;346:1016-1019.
86. Horwitz LD, Myers JH: Ethanol-induced alterations in pancreatic blood flow in conscious dogs. Circ Res 1982;50:250-256.
87. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM: Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991;112:749-759.
88. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-261.
89. 2 receptor antagonist (ONO 3708) on ischemia-reperfusion injury of the dog pancreas. Transplantation 1994;57:187-193.
90. Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA: Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988;82:2045-2055.
91. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:7538-7542.
92. Kubes P, Suzuki M, Granger DN: Platelet-activating factor-induced microvascular dysfunction: Role of adherent leukocytes. Am J Physiol 1990;258:G158-G163.
93. Beekhuizen H, van Furth R: Monocyte adherence to human vascular endothelium. J Leukoc Biol 1993;54:363-378.
94. Norman JG, Fink GW, Franz MG: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-970.
95. Nonaka A, Manabe T, Tamura K, Asano N, Imanishi K, Yamaki K, Tobe T: Organ specific ESR features in mouse main organs and ESR application to the model of pancreatic disorders. Nippon Geka Gakkai Zasshi 1990;91:169-173.
96. 2, and lipid peroxidation in pancreas transplantation. Transplantation 1991;51:987-990.
97. Nonaka A, Manabe T, Tamura K, Asano N, Imanishi K, Tobe T: Changes of xanthine oxidase, lipid peroxide and superoxide dismutase in mouse acute pancreatitis. Digestion 1989;43:41-46.
98. Guice KS, Miller DE, Oldham KT, Townsend CM Jr, Thompson JC: Superoxide dismutase and catalase: A possible role in established pancreatitis. Am J Surg 1986;151:163-169.
99. Nonaka A, Manabe T, Tobe T: Effect of a new synthetic ascorbic acid derivative as a free radical scavenger on the development of acute pancreatitis in mice. Gut 1991;32:528-532.
100. Sanfey H, Bulkley GB, Cameron JL: The pathogenesis of acute pancreatitis: The source and role of oxygen-derived free radicals in three different experimental models. Ann Surg 1985;201:633-639.
101. Sarr MG, Bulkley BG, Cameron JL: Temporal efficacy of allopurinol during the induction of pancreatitis in the ex vivo perfused canine pancreas. Surgery 1987;101:342-346.
102. Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA: Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989;210:740-747.
103. Braganza J, Rinderknecht H: Free radicals and acute pancreatitis. Gastroenterology 1988;94:1111-1112.
104. Keim V, Iovanna JL, Dagorn J-C: The acute phase reaction of the exocrine pancreas. Gene expression and synthesis of pancreatitis-associated proteins. Digestion 1994;55:65-72.
105. Kusske AM, Rongione AJ, Reber HA: Cytokines and acute pancreatitis. Gastroenterology 1996;110:639-642.
106. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-655.
107. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Senkin A, Imrie CW: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-45.
108. Leser H-G, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J: Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
109. 2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1993;38:33-38.
110. Konturek SJ, Dembinski A, Konturek PJ, Warzecha Z, Jaworek J, Gustav P, Tomaszewska R, Stachura J: Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut 1992;33:1268-1274.
111. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, Matsuura N, Mori T: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995;23:901-908.
112. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO: Amelioration of the physiologic and biochemical changes in acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994;167:214-219.
113. Guice KS, Oldham KT, Remick DG, Kunkel SL, Ward PA: Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced pancreatitis. J Surg Res 1991;51:495-499.
114. Hoffmann TF, Leiderer R, Waldner H, Messmer K: Bradykinin antagonists HOE-140 and CP-0597 diminish microcirculatory injury after ischaemia-reperfusion of the pancreas in rats. Br J Surg 1996;83:189-195.
115. Targarona EM, Hotter G, López-Boado MA, Ramos E, Closa D, Rosello J, Puig-Parallada P, Gelpi E, Fernández-Cruz L: Experimental pancreas transplantation: Prevention of lipid peroxidation in the ischemia-reperfusion syndrome. Transplant Proc 1992;24:9-10.
116. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H827.
117. Lerman A, Burnett JC Jr: Intact and altered endothelium in regulation of vasomotion. Circulation 1992;86(suppl):III12-III19.
118. Lüscher TF, Yang Z, Tschudi M, Segesser LV, Stulz P, Boulanger C, Siebenmann R, Turina M, Bühler FR: Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088-1094.
119. Warner TD, Mitchell JA, DeNicci G, Vane JR: Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 1989;13(suppl 5):S85-S88.
120. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr: Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992;85:1894-1898.
121. Tsuji S, Kawano S, Michida T, Masuda E, Nagano K, Takei Y, Fusamoto H, Kamada T: Ethanol stimulates immunoreactive endothelin-1 and -2 release from cultured human umbilical vein endothelial cells. Alcohol Clin Exp Res 1992;16:347-349.
122. Akimoto M: Endothelin levels under water-immersion stress in rats. Gastroenterol Jpn 1992;89:1982-1989.
123. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin levels in patients with essential hypertension. N Engl J Med 1990;322:205.
124. Schiffrin EL, Thibauly G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991;4:303-308.
125. Stewart DJ, Levy RD, Carnacek P, Langleben D: Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 1991;14:646-650.
126. Itoh K, Goseki N, Yoshino K, Endo M, Hirata Y, Marumo F: Changes of endothelin in human plasma after surgery: Preliminary report. J Jpn Surg Soc 1990;91:296.
127. Takaori K, Inoue K, Kogire M, Higashide S-I, Tun T, Aung T, Doi R, Fujii N, Tobe T: Effects of endothelin on microcirculation of the pancreas. Life Sci 1992;51:615-622.
128. Plusczyk T, Bersal B, Westermann S, Menger MD, Feifel G: ET-1 induces pancreatitis-like microvascular deterioration and acinar cell injury. J Surg Res 1999;85:301-310.
129. Plusczyk T, Bersal B, Menger MD, Feifel G: Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation. Dig Dis Sci 2001;46:1343-1351.
130. Liu XH, Kimura T, Ishikawa H, Yamaguchi H, Furukawa M, Nakano I, Kinjoh M, Nawata H: Effect of endothelin-1 on the development of hemorrhagic pancreatitis in rats. Scand J Gastroenterol 1995;30:276-282.
131. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ: Endothelin mediates local and systemic disease sequelae in severe experimental pancreatitis. Pancreas 2001;22:248-254.
132. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ: Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg 1998;228:670-675.
133. Eibl G, Buhr HJ, Foitzik T: Therapy of microcirculatory disorders in severe acute pancreatitis: What mediators should we block? Intensive Care Med 2002;28:139-146.
134. Pohl U, Busse R: Hypoxia stimulates the release of endothelium-derived relaxant factor (EDRF). Am J Physiol 1989;256:H1595-H1600.
135. Xu X-P, Pollock JS, Tanner MA, Myers PR: Hypoxia activates nitric oxide synthase and stimulates nitric oxide production in porcine coronary resistance arteriolar endothelial cells. Cardiovasc Res 1995;30:841-847.
136. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268:L699-L722.
137. Xie J, Wang Y, Lippton H, Cai B, Nelson S, Kolls J, Summer W, Greenberg SS: Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide. Am Rev Respir Dis 1993;148:627-636.
138. Aoki N, Siegfried M, Lefer AM: Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol 1989;256:H1509-H1512.
139. Greenberg S, Xie J, Wang Y, Cai B, Kolls J, Nelson S, Hyman A, Summer WR, Lippton H: Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J Appl Physiol 1993;74:2394-2403.
140. Yoshizumi M, Perella MA, Burnett JC, Lee ME: Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shorthening its half-life. Circ Res 1993;73:205-209.
141. Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-394.
142. Moncada S: The L-arginine:nitric oxide pathway. Acta Physiol Scand 1992;145:201-227.
143. Rau B, Bauer A, Wang A, Gansauge F, Weidenbach H, Nevalainen T, Poch B, Beger HG, Nussler AK: Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: Role of anti-ICAM-1 and oxygen free radical scavengers. Ann Surg 2001;233:195-203.
144. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
145. Viola G, Al-Mufti RA, Sohail M, Williamson RC, Mathie RT: Nitric oxide induction in a rat model of selective pancreatic ischemia and reperfusion. Hepatogastroenterology 2000;47:1250-1255.
146. Ischiropoulos H, Zhu L, Beckman J: Peroxy-nitrite formation from macrophages-derived nitric oxide. Arch Biochem Biophys 1992;298:446-451.
147. Estrada C, Gomez C, Martin C, Moncada S, Gonzalez C: Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun 1992;186:475-482.
148. Palmer RMJ, Bridge L, Foxwell NA, Moncada S: The role of nitric oxide in endothelial cell damage and its inhibition by glycocorticoids. Br J Pharmacol 1992;105:11-12.
149. Dabrowski A, Gabryelewicz A: Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis. Scand J Gastroenterol 1994;29:943-948.
150. Lomis TJ, Siffring CW, Chalasani S, Ziegler DW, Lentz KE, Stauffer KE, McMillan A, Agarwal N, Lowenstein CJ, Rhoads JE: Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis. Am J Surg 1995;61:7-10.
151. Mikawa K, Kodama SI, Nishina K, Obara H: ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats. Crit Care Med 2001;29:1215-1221.
152. Simsek I, Mas MR, Yasar M, Ozyurt M, Saglamkaya U, Deveci S, Comert B, Basustaoglu A, Kocabalkan F, Refik M: Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis. Pancreas 2001;23:296-301.
153. Hotter G, Closa D, Pi F, Prtas N, Fernández-Cruz L, Bulbena O, Gelpi E, Roselló-Catafau J: Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation 1995;59:417-421.
154. Ayub K, Serracino-Inglott F, Williamson RCN, Mathie RT: Expression of inducible nitric oxide synthase contributes to the development of pancreatitis following pancreatic ischaemia and reperfusion. Br J Surg 2001;88:1189-1193.
155. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A, Van de Loo FA, Britti D, Caputi AP, Thiemermann C: Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 2002;17:416-422.
156. Benz S, Schnabel R, Weber H, Pfeffer F, Wiesner R, von Breitenbuch P, Nizze H, Schareck W, Hopt UT: The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas. Transplantation 1998;66:994-999.
157. Benz S, Obermaier R, Wiessner R, Breitenbuch PV, Burska D, Weber H, Schnabel R, Mayer J, Pfeffer F, Nizze H, Hopt UT: Effect of nitric oxide in ischemia/reperfusion of the pancreas. J Surg Res 2002;106:46-53.
158. Liu X, Nakano I, Yamaguchi H, Ito T, Goto M, Koyanagi S, Kinjoh M, Nawata H: Protective effects of nitric oxide on development of acute pancreatitis in rats. Dig Dis Sci 1995;40:2162-2169.
159. Masamune A, Shimosegawa T, Satoh A, Fujita M, Sakai Y, Toyota T: Nitric oxide decreases endothelial activation by rat experimental severe pancreatitis-associated ascitic fluids. Pancreas 2000;20:297-304.